Surface display of co-stimulatory ligand B7H2 on engineered bacteria enhances tumor immunotherapy
The surface-engineered bacteria are reported as the living therapeutic for tumor immunotherapy with outstanding potential for tumor immunotherapy when combined with functional materials or rewired with rationally designed gene circuits.